Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pinus koraiensis Bark Procyanidins Extract (PKBPE) is a natural product derived from the bark of Pinus koraiensis, a plant traditionally used in Chinese medicine for thousands of years. Preclinical studies have demonstrated its antitumor activities, specifically in mice bearing U14 cervical cancer. PKBPE inhibits tumor growth by enhancing the activity of superoxide dismutase (SOD) and decreasing malondialdehyde (MDA) content, suggesting an antioxidant mechanism involving the inhibition of free radical production. Furthermore, it significantly inhibits the expression of Ki-67, mutant p53, and Bcl-2 proteins, which are involved in cell proliferation and apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pinus koraiensis Bark Procyanidins Extract.